US, ex rel. Sun v. Baxter Healthcare Corporation, 1st Cir. (2014)

download US, ex rel. Sun v. Baxter Healthcare Corporation, 1st Cir. (2014)

of 29

Transcript of US, ex rel. Sun v. Baxter Healthcare Corporation, 1st Cir. (2014)

  • 7/26/2019 US, ex rel. Sun v. Baxter Healthcare Corporation, 1st Cir. (2014)

    1/29

    United States Court of AppealsFor the First Circuit

    No. 13- 1732

    UNI TED STATES, EX REL. VEN- A- CARE OF THE FLORI DA KEYS, I NC. ,

    Pl ai nt i f f , Appel l ee,

    v.

    BAXTER HEALTHCARE CORPORATI ON,

    Def endant , Appel l ee,

    v.

    LI NNETTE SUN AND GREG HAMI LTON,

    Appel l ant s.

    No. 13- 2083

    UNI TED STATES, EX REL. LI NNETTE SUN;UNI TED STATES, EX REL. GREG HAMI LTON,

    Pl ai nt i f f s , Appel l ant s,

    v.

    BAXTER HEALTHCARE CORPORATI ON,

    Def endant , Appel l ee.

    APPEALS FROM THE UNI TED STATES DI STRI CT COURT

    FOR THE DI STRI CT OF MASSACHUSETTS

    [ Hon. Pat t i B. Sar i s, U. S. Di str i ct J udge]

  • 7/26/2019 US, ex rel. Sun v. Baxter Healthcare Corporation, 1st Cir. (2014)

    2/29

    Bef or e

    Howar d, Li pez and Bar r on,Ci r cui t J udges.

    Davi d J . Chi zewer , wi t h whomCour t ney R. Baron, Gol dber g KohnLTD. , Laur en J ohn Udden, Freder i ck M. Mor gan, J r . , J enni f er M.Verkamp, Mor gan Ver kamp, LLC, and Mar k Al l en Kl ei nman were onbr i ef , f or appel l ant s.

    St even J . Roman, wi t h whom Mer l e M. DeLancey, J r . , Di ckst ei nShapi r o LLP, Pet er E. Gel haar , and Donnel l y, Conr oy & Gel haar , LLPwer e on br i ef , f or Baxt er Heal t hcar e Cor por at i on, appel l ee.

    J ames J . Br een, wi t h whomThe Br een Law Fi r m, Rand J . Ri kl i n,J ohn E. Cl ar k, and Goode Casseb J ones Ri kl i n Choate & Wat son wer eon br i ef , f or Ven- A- Car e of t he Fl or i da Keys, I nc. , appel l ee.

    December 1, 2014

  • 7/26/2019 US, ex rel. Sun v. Baxter Healthcare Corporation, 1st Cir. (2014)

    3/29

    BARRON, Circuit Judge. Thi s appeal i nvol ves a l awsui t

    agai nst a pharmaceut i cal company f or al l egedl y def r audi ng t he

    f eder al Medi cai d and Medi care pr ogr ams. The sui t i s based on t he

    Fal se Cl ai ms Act , 31 U. S. C. 3729- 3733, an unusual f eder al

    st at ut e t hat al l ows pr i vat e par t i es, cal l ed "r el at or s, " t o st and i n

    f or t he Uni t ed St ates and br i ng what are known as qui t amact i ons. 1

    Because qui t amact i ons l et pr i vat e i ndi vi dual s r ecover damages f or

    wr ongs done t o t he Uni t ed St at es, a speci al t hr eshol d bar - - t he

    "f i r st- t o- f i l e" rul e - - somet i mes st ands i n t hei r way. I t i s t hat

    bar t hat i s i n di sput e her e.

    The f i r st - t o- f i l e r ul e i s so named because i t bl ocks qui

    t am sui t s t hat ar e f i l ed whi l e si mi l ar enough ones ar e al r eady

    pendi ng. I n t hi s case, t he Di st r i ct Cour t r ul ed appel l ant s' qui

    t am sui t coul d not go f orward because a Fl or i da pharmacy years

    bef or e had br ought one a l ot l i ke i t . We agr ee wi t h t he Di st r i ct

    Cour t on t hat poi nt and t hus af f i r m t he di smi ssal of appel l ant s'

    sui t . Because t hat deci si on t akes car e of t hi s appeal , we do not

    deci de t he ot her i ssues t he par t i es di scuss.

    1 " Qui t am i s shor t f or t he Lat i n phr ase qui t am pr o domi nor ege quam pr o se i pso i n hac part e sequi t ur , whi ch means ' whopur sues t hi s act i on on our Lor d t he Ki ng' s behal f as wel l as hi sown. ' " Vt . Agency of Nat ur al Res. v. Uni t ed St at es ex r el .St evens, 529 U. S. 765, 768 n. 1 ( 2000) .

    -3-

  • 7/26/2019 US, ex rel. Sun v. Baxter Healthcare Corporation, 1st Cir. (2014)

    4/29

    I.

    To underst and why we ar e onl y now consi der i ng t he f i r st -

    t o- f i l e r ul e i n a case t hat began ni ne year s ago, we need t o

    descr i be t he t wo qui t am act i ons i nvol ved, t he al l eged f r aud each

    i dent i f i ed, and t he compl i cat ed pr ocedur al pat h t hat l ed t he

    Di st r i ct Cour t t o deci de t hei r si mi l ar i t i es requi r ed t he l at er

    sui t ' s di smi ssal . To do al l of t hat , t hough, we f i r st need t o go

    back near l y t wo decades, t o 1995.

    That was when Ven- A- Car e of t he Fl or i da Keys, I nc. , t he

    phar macy, f i l ed t he f i r st of t he t wo qui t amact i ons i nvol ved her e.

    Ven- A- Care al l eged a number of pharmaceut i cal compani es had

    f r audul ent l y i nf l at ed t he pr i ces of t hei r dr ugs, t hus secur i ng

    hi gher r ei mbur sement s t hrough Medi car e and Medi cai d t han t hey

    deser ved. Among t he many compani es named i n Ven- A- Car e' s compl ai nt

    was Baxt er Heal t hcare Corporat i on.

    Baxt er ' s st at us as a def endant was kept f r ompubl i c vi ew

    f or mor e t han a decade because Ven- A- Car e f i l ed i t s qui t am sui t

    under seal . See 31 U. S. C. 3730( b) ( 2) , ( 3) ( Fal se Cl ai ms Act

    compl ai nt s must be f i l ed i n camera and may be kept under seal at

    t he gover nment ' s behest ) . But i n 2010, t he Uni t ed St ates deci ded

    not t o i nt er vene i n Ven- A- Car e' s case, and t hat l ed t o t he

    compl ai nt ' s unseal i ng. 2 See i d. 3730( b) ( 4) ( B) . The J udi ci al

    2 By t hat poi nt , Ven- A- Care had amended i t s compl ai nt on f ouroccasi ons. The oper at i ve Ven- A- Car e compl ai nt f or pur poses of t hi sappeal i s t he Four t h Amended Compl ai nt , whi ch was f i l ed on December

    -4-

  • 7/26/2019 US, ex rel. Sun v. Baxter Healthcare Corporation, 1st Cir. (2014)

    5/29

    Panel on Mul t i di st r i ct Li t i gat i on t hen consol i dat ed Ven- A- Car e' s

    sui t wi t h near l y one hundr ed si mi l ar act i ons - - most f i l ed under

    l aws ot her t han t he Fal se Cl ai ms Act - - i n t he Uni t ed St at es

    Di st r i ct Cour t f or t he Di st r i ct of Massachuset t s. See I n r e Phar m.

    I ndus. Aver age Whol esal e Pr i ce Li t i g. , 491 F. Supp. 2d 20 ( D. Mass.

    2007) ; I n r e Phar m. I ndus. Aver age Whol esal e Pr i ce Li t i g. , 230

    F. R. D. 61 ( D. Mass. 2005) .

    About a year l at er , i n Oct ober of 2011, Baxt er and

    Ven- A- Care r eached a set t l ement agr eement . Baxt er agreed t o pay

    t ens of mi l l i ons of dol l ar s t o be shar ed bet ween Ven- A- Car e and t he

    Uni t ed St ates. I n r et ur n, t he Set t l ement Agr eement and Rel ease

    pur por t ed t o "f ul l y and f i nal l y rel ease[ ] , acqui t [ ] , and f or ever

    di schar ge[ ] " Baxt er f r om "any and al l ci vi l , r egul at or y, and/ or

    admi ni st r at i ve cl ai m, act i on, sui t , demand, r i ght , cause of act i on,

    l i abi l i t y, j udgment , damage, or pr oceedi ng . . . whi ch has been

    asser t ed, coul d have been asser t ed, or coul d be asser t ed i n t he

    f ut ur e . . . f or or ar i si ng f r om any of t he Cover ed Conduct . " The

    agr eement def i ned "Covered Conduct " as Baxt er ' s submi ss i on of

    i nf l at ed pr i ce and cost f i gur es, and i t s subsequent r ecei pt of

    hi gher - t han- deserved rei mbur sement s, f or "any and al l dr ugs

    manuf act ur ed, mar ket ed and/ or sol d by or on [ i t s] behal f . "

    11, 2002 - - mor e t han t wo years bef or e t he ot her r el at or s i n t hi scase br ought t hei r sui t agai nst Baxt er i n 2005.

    -5-

  • 7/26/2019 US, ex rel. Sun v. Baxter Healthcare Corporation, 1st Cir. (2014)

    6/29

    Despi t e t hat agr eement , t he Fal se Cl ai ms Act pr event ed

    Ven- A- Car e f r om vol unt ar i l y di smi ssi ng i t s act i on agai nst Baxt er

    wi t hout t he f eder al gover nment ' s consent . See 31 U. S. C.

    3730( b) ( 1) . But Ven- A- Car e soon di d get t hat consent , and t he

    Di st r i ct Cour t t hen ent er ed j udgment di smi ssi ng Ven- A- Car e' s act i on

    agai nst Baxt er , t hus seemi ngl y endi ng Baxt er ' s r ol e i n t he case.

    Baxt er ' s i nvol vement i n Fal se Cl ai ms Act l i t i gat i on, however , was

    not over . I nst ead, a new f r ont of l i t i gat i on had opened.

    Years bef or e t he di smi ssal of Ven- A- Car e' s sui t , Li nnet t e

    Sun, one of Baxt er ' s f ormer empl oyees, and Gr eg Hami l t on, an

    empl oyee of one of i t s l ongt i me cust omers, 3 had teamed up to f i l e

    a qui t am act i on of t hei r own agai nst Baxt er , and t hat act i on was

    st i l l pendi ng when Baxter set t l ed wi t h Ven- A- Car e. 4 Ven- A- Care and

    Baxter were aware of Sun and Hami l t on' s sui t when t hey concl uded

    t hei r set t l ement t al ks, but t hey di d not di r ect l y al er t Sun and

    3 Sun was a r esear ch di r ect or f or Baxt er , and i n t hat capaci t ywas r esponsi bl e f or pr i ci ng one of t he dr ugs l i st ed i n her andHami l t on' s compl ai nt . Hami l t on worked f or a pharmacy t hatpur chased Baxter ' s pr oduct s and used one of t he commerci alr epor t i ng compendi a al l egedl y cr uci al t o t he f r aud Baxt er car r i edout .

    4 Par t l y as a r esul t of t he f act t hat Sun and Hami l t on f i l edt hei r act i on bef or e Ven- A- Car e' s was publ i cl y di scl osed, t hi s casedoes not i mpl i cat e t he Fal se Cl ai ms Act ' s " publ i c di scl osur e" bar ,31 U. S. C. 3730( e) ( 4) . See gener al l y Uni t ed St at es ex r el .Duxbur y v. Or t ho Bi ot ech Pr ods. , L. P. , 579 F. 3d 13, 20- 28 ( 1st Ci r .2009) ( anal yzi ng t ext , hi st or y, and st r uct ur e r el evant t o "publ i cdi scl osur e" bar ) . The par t i es do not ar gue ot her wi se.

    -6-

  • 7/26/2019 US, ex rel. Sun v. Baxter Healthcare Corporation, 1st Cir. (2014)

    7/29

    Hami l t on t o t hei r i mpendi ng agr eement . 5 I nst ead, af t er t he Uni t ed

    St at es s i gned of f on Baxter ' s set t l ement wi t h Ven- A- Car e and t hat

    sui t had been di smi ssed, Baxt er moved f or part i al 6 summar y j udgment

    i n Sun and Hami l t on' s case.

    I n doi ng so, Baxt er argued t he Ven- A- Care set t l ement

    r el eased not onl y t he phar macy' s cl ai ms agai nst i t , but al so Sun

    and Hami l t on' s cl ai ms as wel l . Sun and Hami l t on count er ed t hey

    wer e not par t i es t o t he Ven- A- Car e act i on and t he Uni t ed St at es' s

    consent t o t he set t l ement was, as t he gover nment put i t , " t o t he

    di smi ssal wi t h pr ej udi ce onl y of cl ai ms pl ed i n r el at or

    Ven- A- Car e' s compl ai nt agai nst [ Baxt er ] . " St at ement of t he Uni t ed

    St ates Regardi ng t he Consent of t he Uni t ed St ates t o t he Di smi ssal

    wi t h Pr ej udi ce of Cl ai ms Pur suant t o 31 U. S. C. 3730( b) ( 1) i n a

    Rel at ed Mat t er , I n r e Phar m. I ndus. Aver age Whol esal e Pr i ce Li t i g. ,

    No. 1: 01- cv- 12257- PBS (D. Mass. Nov. 14, 2011) , ECF No. 7897

    ( emphasi s added) . Sun and Hami l t on t hus ar gued t he Ven- A- Care

    set t l ement agr eement shoul d not be read to rel ease t hei r cl ai ms.

    5 Ven- A- Care di d f i l e t he Set t l ement Agr eement and Rel ease ont he docket t hat appl i ed f or t he ent i r e mul t i di st r i ct l i t i gat i onagai nst al l t he pharmaceut i cal - company- def endant s, but Ven- A- Care

    di d not pr ovi de Sun and Hami l t on wi t h any f ur t her not i ce of t heagr eement .

    6 Sun and Hami l t on had pr evi ousl y amended t hei r compl ai nt t oadd r et al i at i on and empl oyment di scr i mi nat i on cl ai ms not now bef oreus, but Baxter ' s summary j udgment mot i on was br ought wi t h respectt o t he Fal se Cl ai ms Act cl ai ms onl y.

    -7-

  • 7/26/2019 US, ex rel. Sun v. Baxter Healthcare Corporation, 1st Cir. (2014)

    8/29

    The Di st r i ct Cour t di sagreed, however , and grant ed summar y

    j udgment .

    But Baxt er was st i l l not f r ee and cl ear . Sun and

    Hami l t on ar gued i n a mot i on f or r econsi der at i on t hat even i f t he

    Ven- A- Car e set t l ement di d cover t hei r cl ai ms, t he agr eement coul d

    not r el ease t hose cl ai ms unt i l Sun and Hami l t on got a hear i ng on

    whet her " t he pr oposed set t l ement i s f ai r , adequat e, and r easonabl e

    under al l t he ci r cumst ances. " 31 U. S. C. 3730( c) ( 2) ( B) . Thei r

    argument depended on t hei r charact er i zat i on of t he set t l ement as an

    "al t er nate remedy" t he Uni t ed St ates had chosen t o pur sue f or

    Baxt er ' s f r aud. See i d. 3730( c) ( 5) .

    The Di st r i ct Cour t agreed wi t h Sun and Hami l t on t hat t he

    set t l ement was an "al t er nate remedy" under t he Act , but t hat

    present ed a pr ocedural puzz l e about how Sun and Hami l t on coul d get

    t he f ai r ness hear i ng. Af t er al l , t he Ven- A- Car e sui t had al r eady

    been di smi ssed, and t hus that case was over . The Di st r i ct Cour t

    suggest ed a possi bl e sol ut i on mi ght be avai l abl e t hr ough an

    ar guabl y novel const r uct i on of Feder al Rul e of Ci vi l Pr ocedur e

    60( b) , whi ch al l ows par t i es t o move t o reopen j udgment s i n cer t ai n

    l i mi t ed ci r cumst ances. I n r esponse, Sun and Hami l t on f i l ed a

    mot i on i n Ven- A- Care' s case agai nst Baxt er - - t o whi ch Sun and

    Hami l t on wer e not par t i es - - t hat ar gued t hey had a r i ght t o a

    f ai r ness hear i ng under t he Fal se Cl ai ms Act t hat r equi r ed r eopeni ng

    t he Ven- A- Care j udgment .

    -8-

  • 7/26/2019 US, ex rel. Sun v. Baxter Healthcare Corporation, 1st Cir. (2014)

    9/29

  • 7/26/2019 US, ex rel. Sun v. Baxter Healthcare Corporation, 1st Cir. (2014)

    10/29

    cl ai ms agai nst Baxter . Baxter and Ven- A- Car e def end bot h r ul i ngs

    as appel l ees.

    II.

    The " f i r st - t o- f i l e" r ul e i s, at l east i n t hi s Ci r cui t ,

    j ur i sdi ct i onal . Uni t ed St at es ex r el . Wi l son v. Br i st ol - Myer s

    Squi bb, I nc. , 750 F. 3d 111, 117 ( 1st Ci r . 2014) ( "The FCA

    f i r s t - t o- f i l e r ul e i s j ur i sdi ct i onal . . . . " ) . But cf . Uni t ed

    St at es ex r el . Shea v. Cel l co P' shi p, 748 F. 3d 338, 345- 46 ( D. C.

    Ci r . 2014) ( Sr i ni vasan, J . , concur r i ng i n par t and di ssent i ng i n

    par t ) ( not i ng t hat D. C. Ci r cui t has not def i ni t i vel y r ul ed on

    f i r s t - to- f i l e bar ' s j ur i sdi ct i onal character ) . I f we af f i rm on

    t hat gr ound, t her ef ore, we woul d not r each whet her Baxt er ' s

    set t l ement agr eement wi t h Ven- A- Care i ndependent l y r el eased Sun and

    Hami l t on' s cl ai ms, as t he Di st r i ct Cour t i ni t i al l y hel d. Nor woul d

    we reach whet her t he gover nment , by consent i ng t o t he Ven- A- Care

    set t l ement , secur ed an "al t er nat e remedy" f or Baxt er ' s al l eged

    f r aud, such t hat Sun and Hami l t on wer e ent i t l ed t o a f ai r ness

    hear i ng bef or e t hat set t l ement agr eement coul d t ake ef f ect , as t he

    Di st r i ct Cour t l at er det er mi ned. Nor , f ur t her , woul d we r each

    whether Sun and Hami l t on, as non- par t i es, coul d move to reopen t he

    Ven- A- Car e j udgment , as t he Di st r i ct Cour t al so r ul ed. And so we

    ski p over t hese var i ous i ssues - - t he Di st r i ct Cour t acknowl edged

    t hey pr esent ed a "pr ocedur al pr et zel " - - so we may f ocus on an

    -10-

  • 7/26/2019 US, ex rel. Sun v. Baxter Healthcare Corporation, 1st Cir. (2014)

    11/29

    i ssue t hat pr ecedes t hem al l : whet her t he Di st r i ct Cour t was r i ght

    t o accept Baxt er ' s f i r st - t o- f i l e def ense.

    We begi n wi t h t he port i on of t he Fal se Cl ai ms Act t hat

    gi ves r i se t o t he f i r st- t o- f i l e r ul e: 31 U. S. C. 3730( b) ( 5) . I t

    st at es t hat , when a pr i vat e par t y f i l es a qui t am act i on under t he

    Fal se Cl ai ms Act , "no per son ot her t han t he Gover nment may

    i nt er vene or br i ng a r el at ed act i on based on t he f act s under l yi ng

    t he pendi ng act i on. " 7

    Of cour se, l awsui t s, l i ke anyt hi ng el se, may be " r el at ed"

    al ong many di mensi ons. And t he ways i n whi ch a subsequent f i l i ng

    mi ght be "based on t he f act s" of an ear l i er one are many as wel l .

    But t hi s Ci r cui t has expl ai ned t hat what mat t er s, gi ven t hi s

    st at ut or y l anguage and t he Act ' s under l yi ng pur poses, are t wo

    t hi ngs: ( 1) t he r el at i onshi p bet ween t he f r aud al l eged i n t he t wo

    qui t am act i ons, and ( 2) t he ext ent t o whi ch t he f act s al l eged i n

    t he f i r st - f i l ed qui t am act i on suf f i ce t o pr ovi de t he gover nment

    wi t h not i ce of t he f r aud t hat has been al l eged by t he second. See

    Wi l son, 750 F. 3d at 117- 19; Uni t ed St ates ex rel . Hei neman- Gut a v.

    7 Because Sun and Hami l t on f i l ed t hi s act i on agai nst Baxterwhi l e Ven- A- Car e' s was st i l l under seal - - and t hus was st i l l"pendi ng" - - t he f i r st- t o- f i l e r ul e appl i es t o t hi s act i on even

    t hough t he ear l i er - f i l ed act i on has now been di smi ssed. See Uni t edSt ates ex r el . Hei neman- Gut a v. Gui dant Corp. , 718 F. 3d 28, 34 n. 7( 1st Ci r . 2013) ; cf . Uni t ed St at es ex r el . Car t er v. Hal l i bur t onCo. , 710 F. 3d 171, 182- 84 ( 4t h Ci r . 2013) ( al l owi ng a rel at edact i on t o be f i l ed af t er t he or i gi nal act i on was di smi ssed) , cer t .gr ant ed sub nom. Kel l ogg Br own & Root Ser vs. , I nc. v. Uni t ed St atesex rel . Car t er , 134 S. Ct . 2899 ( 2014) .

    -11-

  • 7/26/2019 US, ex rel. Sun v. Baxter Healthcare Corporation, 1st Cir. (2014)

    12/29

    Gui dant Cor p. , 718 F. 3d 28, 35- 36 ( 1st Ci r . 2013) ; Uni t ed St at es ex

    r el . Duxbur y v. Or t ho Bi ot ech Pr ods. , L. P. , 579 F. 3d 13, 32- 33 ( 1st

    Ci r . 2009) .

    Thi s f ocus makes good sense. By l i mi t i ng when f ol l ow- on

    qui t am sui t s may be br ought , t he Act i n sect i on 3730( b) ( 5) does

    not guar ant ee t hat anyone wi t h usef ul i nf or mat i on about f r audul ent

    conduct agai nst t he Uni t ed St at es may r ecover damages by br i ngi ng

    a sui t based on such knowl edge. Rather , t he Act seeks t o ensure

    t he f eder al gover nment r ecei ves t he i nf or mat i on i t needs t o l aunch

    a meani ngf ul i nvest i gat i on i nt o f r audul ent conduct . Wi l son, 750

    F. 3d at 117. That "pur pose of t he qui t am act i on under 3730( b)

    i s sat i sf i ed" when t he gover nment r ecei ves a compl ai nt t hat

    cont ai ns "' genui nel y val uabl e i nf or mat i on' " of suf f i ci ent l y not i ce-

    suppl yi ng qual i t y. Hei neman- Gut a, 718 F. 3d at 35- 36 ( quot i ng

    Uni t ed St at es ex r el . LaCor t e v. Smi t hKl i ne BeechamCl i ni cal Labs. ,

    I nc. , 149 F. 3d 227, 234 ( 3d Ci r . 1998) ) . And t r eat i ng such a

    f i r st - f i l ed compl ai nt as pr ecl udi ng a si mi l ar enough l at er - f i l ed

    one f ur t her s t he Act ' s pur poses i n another way. Such t r eatment

    "pr ovi de[ s] i ncent i ves t o r el at or s t o pr ompt l y al er t t he

    gover nment " of any f r aud. Wi l son, 750 F. 3d at 117 ( ci t at i on and

    i nt er nal quot at i on mar ks omi t t ed) . Ther e i s t hus no r eason t o r ead

    sect i on 3730( b) ( 5) t o l et l at er - f i l i ng r el at or s sue mer el y because

    t hey of f er addi t i onal i nf or mat i on t hat mi ght al so hel p t he

    gover nment car r y out i t s i nvest i gat i on.

    -12-

  • 7/26/2019 US, ex rel. Sun v. Baxter Healthcare Corporation, 1st Cir. (2014)

    13/29

    Agai nst t hi s backgr ound, t he f i r st - t o- f i l e r ul e r equi r es

    t hat we check t o see whet her t he compl ai nt i n t he f i r st qui t am

    sui t pr ovi ded enough det ai l t o ensure t hat " t he gover nment knows

    t he essent i al f act s of a f r audul ent scheme" - - f or once t he

    government knows t hat much, " i t has enough i nf ormat i on t o di scover

    r el at ed f r auds. " I d. at 118 ( quot i ng Uni t ed St at es ex r el . Br anch

    Consul t ant s v. Al l st at e I ns. Co. , 560 F. 3d 371, 378 ( 5t h Ci r .

    2009) ) . Or , as we have put t he poi nt el sewher e, " t o pr ovi de

    suf f i ci ent not i ce t o t he gover nment of t he al l eged f r aud and bar a

    l at er - f i l ed compl ai nt under 3730( b) ( 5) [ , ] ear l i er - f i l ed

    compl ai nt s must pr ovi de onl y the essent i al f act s t o gi ve t he

    gover nment suf f i ci ent not i ce t o i ni t i at e an i nvest i gat i on i nt o

    al l egedl y f r audul ent pr acti ces" al so al l eged i n t he l at er - f i l ed

    act i on. Hei neman- Gut a, 718 F. 3d at 36- 37.

    I n t hi s way, t he st atement i n Hei neman- Gut a t hat a

    f i r st - f i l ed compl ai nt need pr ovi de onl y "suf f i ci ent not i ce t o

    i ni t i at e an i nvest i gat i on i nt o al l egedl y f r audul ent pr acti ces, " i d.

    at 36- 37, i nf or ms t he "essent i al f act s" t est , i t does not suppl ant

    i t . Bef ore barr i ng a second compl ai nt , we must ask not mer el y

    whet her t he f i r st - f i l ed compl ai nt pr ovi des some evi dence f r omwhi ch

    an ast ut e gover nment of f i ci al coul d arguabl y have been put "on

    not i ce, " i d. at 35, 38, but al so whet her t he f i r st compl ai nt

    cont ai ned "al l t he essent i al f acts" of t he f r aud i t al l eges, i d. at

    34 ( ci t at i on omi t t ed) .

    -13-

  • 7/26/2019 US, ex rel. Sun v. Baxter Healthcare Corporation, 1st Cir. (2014)

    14/29

    Under t hi s "essent i al f acts" st andar d, a l at er - f i l ed

    cl ai m cannot go ahead i f i t " ' st at es al l t he essent i al f acts of a

    pr evi ousl y- f i l ed cl ai m' or ' t he same el ement s of a f r aud descr i bed

    i n an ear l i er sui t . ' " Wi l son, 750 F. 3d at 117 ( quot i ng Duxbur y,

    579 F. 3d at 32) . I t f ol l ows that t her e need not be i dent i t y

    bet ween t he t wo compl ai nt s t o t r i gger t he f i r st - t o- f i l e r ul e.

    " [T]he f i r s t - to- f i l e rul e ' st i l l bar [ s] a l at er c l ai meven i f that

    cl ai m i ncor por at es somewhat di f f er ent det ai l s. ' " I d. at 118

    ( al t er at i on i n or i gi nal ) ( quot i ng Duxbur y, 579 F. 3d at 32) .

    Wi t h t hi s l egal f r amework i n mi nd, we compar e t he Ven- A-

    Care compl ai nt t o t he Sun and Hami l t on compl ai nt . See I n r e

    Nat ur al Gas Royal t i es Qui Tam Li t i g. ( CO2 Appeal s) , 566 F. 3d 956,

    964 ( 10t h Ci r . 2009) ( "The f i r st - t o- f i l e bar i s desi gned t o be

    qui ckl y and easi l y det er mi nabl e, si mpl y requi r i ng a si de- by- si de

    compar i son of t he compl ai nt s. " ) ; Uni t ed St at es ex r el . Pot eet v.

    Medt r oni c, I nc. , 552 F. 3d 503, 516 ( 6t h Ci r . 2009) ( "I n or der t o

    det er mi ne whet her a r el at or ' s compl ai nt r uns af oul of . . .

    3730( b) ( 5) ' s f i r st - t o- f i l e bar , a cour t must compar e t he

    r el at or ' s compl ai nt wi t h t he al l egedl y f i r st - f i l ed compl ai nt . ") .

    I n doi ng so, we revi ew de novo whet her t he f i r st compl ai nt meet s

    t he "essent i al f act s" t est , as t hat t est pr esent s a quest i on of l aw

    about t he st at ut or i l y r equi r ed t hr eshol d f or not i f yi ng t he

    gover nment of t he f r aud al l eged i n t he l at er - f i l ed sui t . Wi l son,

    750 F. 3d at 117.

    -14-

  • 7/26/2019 US, ex rel. Sun v. Baxter Healthcare Corporation, 1st Cir. (2014)

    15/29

    A.

    I n many qui t am sui t s i nvol vi ng t he f i r st- t o- f i l e r ul e,

    a cent r al quest i on i s whet her t he two act i ons concer n t he same

    f r aud or di st i nct ones. But Sun and Hami l t on l ead wi t h a di f f er ent

    cont ent i on. They cl ai m t he Ven- A- Care compl ai nt was so vague and

    concl usory when i t came t o Baxt er ' s conduct t hat i t was as i f t he

    compl ai nt al l eged no f r aud at al l . Thus, t hey ar gue t hat onl y t hey

    "pr ovi ded t he t ype of i nf ormat i on necessary t o gi ve t he Gover nment

    a meani ngf ul head st ar t on i t s i nvest i gat i on" i nt o Baxt er ' s f r aud.

    They st r ess t hey i dent i f i ed "names, meet i ngs, st at ements, and

    document s" speci f i c t o Baxt er ' s f r audul ent scheme, whi l e, t hey

    argue, Ven- A- Care set f or t h none.

    But Sun and Hami l t on are not f ai r t o t he Ven- A- Care

    compl ai nt . The Ven- A- Car e compl ai nt di d l ack t he det ai l Sun and

    Hami l t on' s set s f or t h, but i t was not ber ef t of f acts speci f i c t o

    Baxter ' s al l egedl y f r audul ent conduct . The Ven- A- Car e compl ai nt

    di d at numer ous poi nt s at t r i but e t he f r aud t o t he def endant s

    t hr ough t he use of pl ur al i ndef i ni t e pr onouns, such as " each" or

    "al l . " But t hat way of i dent i f yi ng t he def endant s does not make

    t he Ven- A- Car e compl ai nt any l ess usef ul t o t he f eder al gover nment .

    Baxt er was covered by those same words, and t he Fal se Cl ai ms Act

    sur el y shoul d not be r ead t o di scour age a r el at or f r om al l egi ng a

    f r aud per pet r at ed by many def endants.

    -15-

  • 7/26/2019 US, ex rel. Sun v. Baxter Healthcare Corporation, 1st Cir. (2014)

    16/29

    I n any event , Ven- A- Car e' s compl ai nt cont ai ned a separ at e

    sect i on devot ed sol el y t o Baxt er . I n t hat sect i on, Ven- A- Car e

    al l eged Baxter knowi ngl y made f al se r epr esent at i ons about t he pr i ce

    and cost of i t s dr ugs i n or der t o r ecei ve f r audul ent l y i nf l at ed

    r ei mbur sement s f r omMedi car e and Medi cai d and " f ur t her made or used

    f al se r ecor ds or st at ement s r egar di ng i t s pr i ces and cost s of t he

    dr ugs . . . and submi t t ed same t o [ Medi care and Medi cai d] . " Ven- A-

    Care al so al l eged Baxt er got r ei mbur sed f or a number of dr ugs - -

    i ncl udi ng t he ant i - hemophi l i a dr ug Recombi nate, whi ch Baxt er

    manuf act ur ed - above t hei r t r ue cost s and pr i ces. I ndeed, even

    Sun and Hami l t on acknowl edge Ven- A- Care "di scl osed a pr i ci ng spr ead

    f or Recombi nate. " The cont ent i on t hat Ven- A- Care' s compl ai nt

    ent i r el y l acked Baxt er - speci f i c al l egat i ons, t her ef or e, i s si mpl y

    wr ong.

    Sun and Hami l t on are on st r onger gr ound i n sayi ng t hei r

    compl ai nt showed gr eat er f ami l i ar i t y wi t h how Baxt er pul l ed of f t he

    supposed f r aud. By dr awi ng on t hei r i nsi de knowl edge as a f ormer

    empl oyee of Baxter and a f ormer empl oyee of a l ongst andi ng cust omer

    of Baxt er , r espect i vel y, Sun and Hami l t on di d of f er f ar mor e det ai l

    t han Ven- A- Car e about par t i cul ar act or s wi t hi n Baxt er and t he rol e

    t hose act or s pl ayed. Whet her t hat mat t er s, however , i s a di f f er ent

    i ssue.

    We have made cl ear t he f i r st - t o- f i l e r ul e does not

    necessar i l y pr ot ect mor e det ai l ed, l at er - f i l ed compl ai nt s f r oml ess

    -16-

  • 7/26/2019 US, ex rel. Sun v. Baxter Healthcare Corporation, 1st Cir. (2014)

    17/29

    det ai l ed, ear l i er - f i l ed ones. See Wi l son, 750 F. 3d at 118- 19. So

    l ong as t he f i r st compl ai nt set s f or t h t he "essent i al f act s" of t he

    f r aud al l eged i n t he second compl ai nt , i t does al l i t needs t o do

    under t he f i r st - t o- f i l e r ul e. I d. at 117. Thus, Sun and Hami l t on

    must show not onl y t hat t hey pr ovi ded more detai l t han Ven- A- Care,

    but al so that Ven- A- Car e di d not pr ovi de enough det ai l - - even i f

    i t pr ovi ded some.

    Exact l y how speci f i c a compl ai nt must be t o pr ovi de t he

    "essent i al f act s" i s not somet hi ng we have pr evi ousl y descr i bed

    wi t h pr eci si on. And pr eci si on may be t oo much t o ask, gi ven t he

    cont ext - speci f i c nat ur e of t he i nqui r y. St i l l , i mpor t ant gui dance

    may be f ound i n our deci si on i n Hei neman- Guta.

    Ther e, we expl ai ned t hat , f or pur poses of 31 U. S. C.

    3730( b) ( 5) , a compl ai nt need not cont ai n t he ki nd of det ai l ed and

    par t i cul ar i zed al l egat i ons of f r audul ent conduct - - such as t he

    names of t he par t i cul ar per sons r esponsi bl e f or car r yi ng out

    cer t ai n aspects of an al l eged f r aud - - r equi r ed t o f ul f i l l t he

    hei ght ened pl eadi ng st andar d f or f r aud cases set f or t h i n Feder al

    Rul e of Ci vi l Pr ocedur e 9( b) . 8 See Hei neman- Gut a, 718 F. 3d at 36-

    8 Rul e 9( b) - - whi ch commands t hat "a par t y must st at e wi t hpar t i cul ar i t y t he ci r cumst ances const i t ut i ng f r aud or mi st ake" - -

    r equi r es a compl ai nt maki ng such an al l egat i on t o "speci f y t het i me, pl ace, and cont ent of an al l eged f al se r epr esent at i on. "Hei neman- Gut a, 718 F. 3d at 34 ( quot i ng Uni t ed St ates ex rel . Rostv. Pf i zer , I nc. , 507 F. 3d 720, 731 ( 1st Ci r . 2007) ) . Thespeci f i ci t y needed t o make out a cl ai m of l i abi l i t y agai nst apar t i cul ar def endant , however , may be gr eat er t han t he amount ofdetai l needed t o ensur e the government has what i t needs t o l aunch

    -17-

  • 7/26/2019 US, ex rel. Sun v. Baxter Healthcare Corporation, 1st Cir. (2014)

    18/29

    37. We al so addressed an ar gument much l i ke t he one Sun and

    Hami l t on now pr ess - - t hat an ear l i er - f i l ed qui t am compl ai nt was

    t oo unspeci f i c to bar a l at er - f i l ed qui t amsui t , even i f Rul e 9( b)

    di d not est abl i sh t he mi ni mum amount of det ai l a qui t am compl ai nt

    must pr ovi de t o t r i gger t he Fal se Cl ai ms Act ' s f i r st - t o- f i l e bar .

    Hei neman- Gut a i nvol ved a rel at or who br ought a qui t am

    act i on t hat cl ai med her empl oyer and one of i t s af f i l i at es had

    engaged i n a ki ckback scheme t o pr omot e t he sal e and use of car di ac

    devi ces t hey manuf actur ed. I d. at 29. Thi r t een mont hs bef ore t hat

    r el ator sued, however , anot her f ormer empl oyee had f i l ed a qui t am

    compl ai nt agai nst t he same company. I d. at 30, 32. The second

    r el at or ar gued t he compl ai nt f i l ed by t he f i r st , whi ch t he par t i es

    agr eed "di scl osed a f r audul ent scheme near l y i dent i cal t o t he one

    al l eged i n [ t he second r el at or ' s] compl ai nt , " i d. at 34 n. 8,

    "f ai l [ ed] t he essent i al f acts t est because i t l ack[ ed] al l egat i ons

    t hat t he scheme act ual l y caused physi ci ans t o i mpl ant [ t he

    empl oyer ' s] devi ces or t hat t hose devi ces wer e cover ed by

    Medi care, " i d. at 38 n. 12. We r ej ected t hat ar gument because a

    compl ai nt "need not cont ai n a det ai l ed pl ay- by- pl ay nar r at i on of

    how t he scheme l ed to t he submi ssi on of f al se cl ai ms" t o t r i gger

    t he f i rst - t o- f i l e rul e. I d. I nstead, we f ound "suf f i ci ent " f or

    a meani ngf ul i nvest i gat i on i nt o t he al l eged f r aud. See i d. at 35( "[ T] he al l egat i ons of a pr ecl usi ve f i r st - f i l ed compl ai nt under 3730( b) ( 5) need not compor t wi t h Rul e 9( b) ' s pl eadi ngr equi r ement s t o pr ovi de t he gover nment wi t h suf f i ci ent not i ce ofpot ent i al f r aud. ") .

    -18-

  • 7/26/2019 US, ex rel. Sun v. Baxter Healthcare Corporation, 1st Cir. (2014)

    19/29

    pur poses of sect i on 3730( b) ( 5) t he f i r st compl ai nt ' s al l egat i ons

    t hat t he company "caused f al se st at ement s and cl ai ms t o be made to

    t he government f or r ei mbur sement under Medi care" " t hr ough mul t i pl e

    f or ms of ki ckbacks desi gned t o i nduce physi ci ans and hospi t al s t o

    use [ t hei r ] devi ces. " I d.

    Ven- A- Car e' s compl ai nt , t oo, di d not of f er a "pl ay- by-

    pl ay" of event s or a det ai l ed nar r at i on of how t he al l eged f r aud

    pl ayed out . But t he compl ai nt di d i dent i f y t he key hi ghl i ght s

    about how Baxter conduct ed t he supposed f r aud. The compl ai nt

    det ai l ed t he par t i cul ar pr i ci ng mechani smBaxt er used f or car r yi ng

    out t he al l eged f r aud ( l ever agi ng t he knowl edge t hat Medi care and

    Medi cai d based t hei r r ei mbur sement payment s on cost and pr i ce

    est i mat es t hat wer e repor t ed by var i ous commer ci al l y avai l abl e dr ug

    pr i ci ng compendi a, and t hus ent er i ng i nt o speci al "char ge- back"

    ar r angement s wi t h sel ect whol esal er s i n or der t o ar t i f i ci al l y

    i nf l ate t he est i mates t hat wer e suppl i ed t o t he compendi a and t hen

    r epor t ed by t hem) . The compl ai nt speci f i ed t he dr ugs i nvol ved

    ( i ncl udi ng, among many other s, t he ant i - hemophi l i c Recombi nate) .

    The compl ai nt descr i bed t he t i me per i od dur i ng whi ch t he scheme

    occur r ed ( " t he per i od st ar t i ng f r omon or bef or e December 31, 1993

    and cont i nui ng thr ough" t he date on whi ch i t was f i l ed, December

    11, 2002) . And t he compl ai nt set f or t h what Ven- A- Care cont ended

    was cor r obor at i ng evi dence of Baxter ' s f r aud ( namel y, a char t

    l i st i ng var i ous r epor t ed cost s and pr i ces) .

    -19-

  • 7/26/2019 US, ex rel. Sun v. Baxter Healthcare Corporation, 1st Cir. (2014)

    20/29

    Ven- A- Care' s compl ai nt t hus har dl y r esembl es t he exampl e

    Sun and Hami l t on ci t e i n t hei r br i ef of a compl ai nt t hey cont end

    coul d not possi bl y t r i gger t he f i r st - t o- f i l e bar : "a one- sent ence

    compl ai nt st at i ng not hi ng mor e t han: ' Baxt er i s commi t t i ng pr i ci ng

    f r aud agai nst t he Gover nment . ' " Nor i s the Ven- A- Care compl ai nt

    t he ki nd of "over l y br oad and specul at i ve compl ai nt " we have

    i ndi cat ed cannot suf f i ce " t o not i f y t he gover nment of a f r audul ent

    scheme. " I d. at 38. I nst ead, Ven- A- Car e' s compl ai nt cont ai ned

    "t he essent i al f act s" of Baxt er ' s al l eged f r aud, and t hus gave "t he

    gover nment suf f i ci ent not i ce t o i ni t i at e an i nvest i gat i on i nt o

    al l egedl y f r audul ent pr act i ces. " I d. at 36- 37.

    Thi s concl usi on i s consi st ent wi t h our ot her f i r st - t o-

    f i l e pr ecedent s, even t hough Sun and Hami l t on say other wi se. Sun

    and Hami l t on r el y i n part i cul ar on our deci si on i n Duxbur y. Ther e,

    we hel d an ear l i er - f i l ed qui t am compl ai nt about an al l egedl y

    f r audul ent scheme i nvol vi ng dr ug pr i ci ng di d not bar a second

    r el at or ' s l at er - f i l ed sui t al l egi ng t he same def endant had engaged

    i n an of f - l abel pr omot i on scheme. 9 579 F. 3d at 32- 33. St andi ng on

    9 I n Duxbur y, t he or i gi nal compl ai nt f i l ed by t he f i r str el at or cont ai ned t wo count s, one al l egi ng "subst ant i ve" Fal seCl ai ms Act vi ol at i ons, and t he ot her al l egi ng conspi r acy. 579 F. 3dat 17. I n suppor t of t he "subst ant i ve" vi ol at i ons, t he compl ai nt

    al l eged ( 1) t hat t he def endant had publ i shed a f r audul ent l yi nf l at ed aver age whol esal e pr i ce f or Pr ocr i t , an anemi a dr ug; ( 2)t hat i t had mar ket ed t he "spread" bet ween t he i nf l at ed pr i ce andt he t r ue pr i ce as a way of i nduci ng heal t hcar e pr ovi der s t opur chase t he dr ug; and ( 3) t hat i t had under t aken "phony dr ugst udi es" i n encour agi ng heal t hcar e pr ovi der s t o pr escr i be Pr ocr i tf or non- appr oved uses. I d.

    -20-

  • 7/26/2019 US, ex rel. Sun v. Baxter Healthcare Corporation, 1st Cir. (2014)

    21/29

    i t s own, Duxbur y mi ght be r ead to suppor t Sun and Hami l t on' s

    posi t i on. Duxbur y di d say t he l at er - f i l ed compl ai nt "cont ai ned a

    number of al l egat i ons t hat di scuss, i n si gni f i cant det ai l , " t he

    al l eged of f - l abel pr omot i on scheme, and Duxbur y di d al l ow t hat

    second, mor e det ai l ed compl ai nt t o sur vi ve t he f i r st - t o- f i l e bar .

    I d. at 33 ( emphasi s added) .

    But our deci si on t o al l ow t he second sui t t o go f or war d

    i n Duxbur y di d not r est on t he gr eat er det ai l i n t he l at er

    compl ai nt . I nst ead, as we l at er expl ai ned i n Wi l son, t he key

    di f f er ence was t hat t he l at er - f i l ed compl ai nt "al l eged a compl ex

    of f - l abel pr omot i on and di r ect mar ket i ng scheme, " whi l e t he

    or i gi nal compl ai nt f ocused on ki ckbacks and i n f act " ' nowher e

    The l at er - f i l ed compl ai nt - - whi ch, l i ke t he f i r st one, wasf i l ed by a f or mer sal es r epr esent at i ve of t he def endant company - -al so al l eged t he company had pai d ki ckbacks t o heal t hcare pr ovi der s

    i n or der t o i nduce t hem t o wr i t e pr escri pt i ons f or Pr ocri t t hatwoul d ot her wi se not have been wr i t t en. I d. at 18. But t he newcompl ai nt addi t i onal l y al l eged t hat t he company had engaged i n acomprehensi ve scheme t o promot e "a dosi ng r egi men of 40, 000 uni t sonce per week even though i t had not r ecei ved appr oval f r omt he FDAf or such a hi gh dosage, " and t hat t he company' s wi despr ead"pr omot i on of t hi s of f - l abel use caused t he f i l i ng of f al se cl ai msf or r ei mbur sement wi t h Medi care and Medi cai d, i nsof ar as t hepr ovi ders sought r ei mbur sement f or nonr ei mbur seabl e uses. " I d.( i nt er nal quot at i on mar ks omi t t ed) .

    I n suppor t of t hi s l at t er al l egat i on, t he second compl ai ntenumerat ed a number of pr omot i on ef f or t s t he def endant al l egedl y

    had under t aken, det ai l i ng t he many ways i n whi ch t he companycar r i ed out t he of f - l abel pr omot i on scheme. See i d. at 33. Bycont r ast , t he f i r st compl ai nt r ef er enced onl y a si ngl e dr ug st udy" i n whi ch [ t he def endant ] al l egedl y pai d physi ci ans t o dose Pr ocr i tat 40, 000[ uni t s] i n a once per week dose i nst ead of t he FDAappr oved dosage of 10, 000[ uni t s] t hr ee t i mes per week dosage i ncancer - chemot her apy pat i ent s. " I d. at 17.

    -21-

  • 7/26/2019 US, ex rel. Sun v. Baxter Healthcare Corporation, 1st Cir. (2014)

    22/29

    r ef er [ r ed] t o an of f - l abel pr omot i on scheme. ' " Wi l son, 750 F. 3d at

    119 ( al t er at i on i n or i gi nal ) ( quot i ng Duxbur y, 579 F. 3d at 33) .

    Thus, even i f t he i ni t i al compl ai nt i n Duxbur y provi ded some

    evi dence r el evant t o t he "compl ex of f - l abel pr omot i on and di r ect

    mar ket i ng scheme, " i t st i l l di d not pr ovi de t he "essent i al f act s"

    about t he compl ex f r aud because t hat f r aud was descr i bed and

    i dent i f i ed onl y i n t he l at er - f i l ed compl ai nt and "nowher e" i n t he

    ear l i er one. I d.

    So under st ood, Duxbur y i s a ver y di f f er ent case f r omt hi s

    one. Wi t h one possi bl e caveat we addr ess bel ow, Sun and Hami l t on

    and Ven- A- Car e do not di sput e t hat t hei r r espect i ve compl ai nt s each

    f ocused on t he same f r audul ent scheme. And, as we have expl ai ned,

    each descr i bed t hat scheme i n si gni f i cant det ai l . The onl y

    di ver gence i n t hei r compl ai nt s, t her ef or e, i s t he same one we

    t hought t oo sl i ght i n Wi l son. As t her e, t he l at er r el at or s her e

    ( Sun and Hami l t on) i ncl uded many det ai l s about t he under l yi ng

    scheme t he f i r st r el at or ( Ven- A- Car e) di d not suppl y. But t he use

    of compar at i vel y gr eat er det ai l i n descr i bi ng t he same under l yi ng

    f r aud i s not what mat t er s f or t he f i r st - t o- f i l e r ul e. Ot her wi se,

    t he "essent i al f act s" t est woul d be r educed t o an "i dent i cal f act s"

    t est . See Wi l son, 750 F. 3d at 118- 19. And, as we expl ai ned i n

    Wi l son, such an under st andi ng of t he "essent i al f act s" t est cannot

    be r i ght because "once t he government knows t he essent i al f act s of

    a f r audul ent scheme, i t has enough i nf or mat i on t o di scover r el at ed

    -22-

  • 7/26/2019 US, ex rel. Sun v. Baxter Healthcare Corporation, 1st Cir. (2014)

    23/29

    f r auds. " 10 750 F. 3d at 118 ( quot i ng Br anch Consul t ant s, 560 F. 3d

    at 378) .

    Si mpl y put , once t he gover nment get s suf f i ci ent l y

    val uabl e i nf or mat i on f r oma qui t am compl ai nt about t he same f r aud

    al l eged by a f ol l ow- on compl ai nt , t he pur poses of t he f i r st - t o- f i l e

    r ul e have been f ul l y ser ved. 11 And her e, both compl ai nt s f ocused

    on t he ver y same f r aud Baxt er al l egedl y commi t t ed, and t he f i r st of

    t he compl ai nt s, Ven- A- Car e' s, pr ovi ded enough speci f i c i nf or mat i on

    about t he al l eged f r aud t o sat i sf y t he f i r st- t o- f i l e r ul e.

    B.

    Sun and Hami l t on do make one f i nal argument . Thi s one

    does not f ocus on t he compar at i vel y gr eat er det ai l t hey suppl i ed

    about t he f r aud i n quest i on, or on t he supposedl y i nsuf f i ci ent

    det ai l Ven- A- Car e of f er ed. I nst ead, Sun and Hami l t on ar gue t hei r

    compl ai nt - - and t hei r s al one - - sket ched out t he i nner wor ki ngs of

    Baxter ' s f r audul ent scheme af t er t he year 2000, and t hat Baxter ' s

    post - 2000 conduct r esul t ed i n a f r audul ent scheme separ at e f r omt he

    f r aud Ven- A- Car e i dent i f i ed. Thus, at l east as t o Baxt er ' s post -

    2000 conduct , Sun and Hami l t on por t r ay t hemsel ves t o be l i ke t he

    10 Al l ot her Ci r cui t s t o have addr essed t he i ssue have t husr ej ect ed an "i dent i cal f act s" t est . See Uni t ed St at es ex r el .

    Chovanec v. Apr i a Heal t hcar e Gr p. I nc. , 606 F. 3d 361, 363 ( 7t h Ci r .2010) ( col l ect i ng cases) .

    11 At l east, t hi s i s tr ue so l ong as the f i r st r el at or ' s sui tr emai ns pendi ng. See gener al l y Car t er , 710 F. 3d at 182- 84, cer t .gr ant ed sub nom. Kel l ogg Br own & Root Ser vs. , I nc. v. Uni t ed St atesex rel . Car t er , 134 S. Ct . 2899 ( 2014) .

    -23-

  • 7/26/2019 US, ex rel. Sun v. Baxter Healthcare Corporation, 1st Cir. (2014)

    24/29

    second r el at or i n Duxbur y - - t he onl y one who suf f i ci ent l y al l eged

    t he compl ex of f - l abel pr omot i on scheme. 12

    Thi s ar gument woul d have some f or ce i f t r ue. But Sun and

    Hami l t on' s compl ai nt suggest s Baxt er ' s f r aud di d not change much

    af t er 2000 - - or , at l east , not enough t o di st i ngui sh i t f r om t he

    f r aud descr i bed i n t he Ven- A- Car e compl ai nt .

    Accor di ng t o Sun and Hami l t on, i n 2000 the New Yor k

    Medi cai d Fr aud Cont r ol Uni t appr i sed var i ous phar macy di r ect or s of

    a pat t er n of mi sr epr esent at i ons by dr ug manuf act ur er s of t he

    aver age whol esal e pr i ces and acqui si t i on cost s of t hei r drugs. As

    a r esul t , Sun and Hami l t on al l eged, some of t he i ndust r y r epor t i ng

    compendi a agr eed t o st op r epor t i ng aver age whol esal e pr i ce val ues

    publ i shed by dr ug manuf act ur er s and to i nst ead repor t f i gur es on

    t he basi s of t r ue mar ket pr i ces.

    Sun and Hami l t on al l eged Baxt er got around t hi s new

    pr act i ce by pr ovi di ng t he compendi a wi t h what Baxt er cal l ed " l i st

    sal es pr i ces. " Al t hough t hey went by a di f f er ent name, t hese " l i st

    sal es pr i ces" - - l i ke t he manuf act ur er - pr ovi ded aver age whol esal e

    pr i ces t he compendi a now r ef used t o accept - - al so ref l ect ed

    ar t i f i ci al l y i nf l at ed amount s pai d by onl y a f ew sel ect whol esal er s

    12At oral argument , Sun and Hami l t on expr essl y di scl ai med thatt hei r compl ai nt al l eged a new scheme by vi r t ue of t he f act t hatonl y t hey made al l egat i ons wi t h r espect t o Baxt er ' s pr i ci ng ofAdvat e, a dr ug Baxt er r el eased onl y af t er Ven- A- Car e f i l ed i t soper at i ve compl ai nt but t hat bot h par t i es agr ee i s, as t he Di st r i ctCour t f ound, ver y cl osel y r el at ed t o t he ot her Baxt er dr ug at i ssuei n Sun and Hami l t on' s compl ai nt , Recombi nat e.

    -24-

  • 7/26/2019 US, ex rel. Sun v. Baxter Healthcare Corporation, 1st Cir. (2014)

    25/29

    wi t h whom Baxter had ent er ed i nt o speci al "char ge- back" deal s. 13

    Sun and Hami l t on f ur t her cl ai med t hat , by suppl yi ng as " l i st sal es

    pr i ces" onl y what t he f ew "char ge- back" whol esal er s pai d, Baxter

    pr ovi ded t he compendi a val ues t hat "bor e no rel at i onshi p t o the

    pr i ce char ged i n t he market pl ace. " And because t he compendi a

    ul t i mat el y accept ed t hese "l i st sal es pr i ces" and t hen r epor t ed

    t hem, Sun and Hami l t on al l eged Baxt er was abl e to obt ai n "a

    subst ant i al spread" bet ween t he pr i ces i t charged t he over whel mi ng

    maj or i t y of i t s buyer s and t he amount s i t r ecei ved i n

    r ei mbur sement s f r om t he gover nment .

    Accordi ng t o Sun and Hami l t on, t hey al one descr i bed t hi s

    post - 2000 f r aud. And, t o bol st er t hat cont ent i on, Sun and Hami l t on

    argue Ven- A- Care' s compl ai nt coul d not possi bl y have pr ovi ded t he

    "essent i al f act s" about Baxt er ' s post - 2000 f r aud because t hat

    ear l i er - f i l ed compl ai nt "cont ai n[ ed] no al l egat i ons r el at i ng t o

    [ Baxt er ' s] post - 1999 conduct . " But t he sect i on of Ven- A- Car e' s

    compl ai nt speci f i c t o Baxt er began by al l egi ng t hat , " [ t ] hr oughout

    t he per i od st ar t i ng f r om on or bef or e December 31, 1993 and

    cont i nui ng thr ough t he pr esent dat e, " Baxt er "knowi ngl y caused

    13 Al t hough Sun and Hami l t on r ef er r ed t o t hese deal s f r equent l y

    i n t hei r compl ai nt , t hey di d not expl ai n t he nat ur e of t he "char ge-back" deal s. By cont r ast , Ven- A- Car e di d. I t s compl ai nt st at edt he "char ge- back" deal s i nvol ved sel ect whol esal er s pur chasi ngdr ugs f r om manuf act ur er s at f ar - above- mar ket pr i ces, knowi ng t hemanuf act ur er s woul d r epay t hem ( and pay t hem a ser vi ce f ee f ort hei r t r oubl es) af t er t hey sol d t he pr oduct s t o r et ai l er s at mar ketval ue.

    -25-

  • 7/26/2019 US, ex rel. Sun v. Baxter Healthcare Corporation, 1st Cir. (2014)

    26/29

    Medi car e/ Medi cai d t o pay f al se or f r audul ent cl ai ms f or

    pr escr i pt i on dr ugs and bi ol ogi cal s. " Si nce Ven- A- Car e' s

    l ast - amended compl ai nt was f i l ed on December 11, 2002, Ven- A- Care' s

    al l egat i ons cover ed near l y thr ee year s' wor t h of "post - 1999

    conduct " speci f i c t o Baxt er . So, on t he t i mi ng poi nt , Sun and

    Hami l t on are si mpl y wr ong. 14

    Sun and Hami l t on al so ar gue Ven- A- Care' s compl ai nt ,

    r egar dl ess of t he t i me- span i t addr esses, sai d t oo l i t t l e about

    what Baxter di d to adj ust t o t he compendi a' s change i n pr act i ce

    af t er 2000. But t hi s ar gument , t oo, i s not r i ght . Ven- A- Car e' s

    compl ai nt st ated t he named def endant s ( Baxt er i ncl uded) f r equent l y

    pr ovi ded cost and pr i ce f i gur es t o the repor t i ng compendi a i n t er ms

    of "Li st Pr i ce" i nst ead of t r ue mar ket pr i ces. And t he compl ai nt

    al l eged each or al l of t he named def endant s pr ovi ded t he compendi a

    wi t h cost and pr i ce f i gur es f r om t he "char ge- back" whol esal er s,

    t her eby obt ai ni ng t he pr obl emat i c gai ns. These are t he ver y same

    mechani sms Sun and Hami l t on i dent i f y i n t hei r compl ai nt . I n f act ,

    Ven- A- Car e' s compl ai nt of f er ed mor e det ai l s about t he "char ge- back"

    mechani sm t han di d Sun and Hami l t on' s compl ai nt .

    14 The Sevent h Ci r cui t has expl ai ned t hat t he f act t hat anear l i er - f i l ed compl ai nt cover s a ti me per i od pr i or t o t he per i odcover ed i n a l at er - f i l ed compl ai nt does not i n and of i t sel f r endert he t wo compl ai nt s unr el at ed f or f i r st - t o- f i l e pur poses, seeChovanec, 606 F. 3d at 363, but we need not r esol ve t hat quest i onsi nce t he Ven- A- Care compl ai nt does descr i be a f r aud t hat ext endedwel l past 2000.

    -26-

  • 7/26/2019 US, ex rel. Sun v. Baxter Healthcare Corporation, 1st Cir. (2014)

    27/29

    Thus, whi l e Sun and Hami l t on i n most r espect s provi ded

    more det ai l about exact l y what Baxt er di d af t er t he compendi a

    shi f t ed t hei r r epor t i ng pr act i ces, any meani ngf ul di f f er ences

    bet ween Baxter ' s pr e- 2000 and post - 2000 f r aud were ones about whi ch

    Ven- A- Car e' s compl ai nt pr ovi ded t he "essent i al f act s. " Thi s

    concl usi on f ol l ows because a r evi ew of Ven- A- Care' s compl ai nt shows

    t hat , what ever i t may have l ef t out , i t di d gi ve t he f eder al

    gover nment suf f i ci ent not i ce t o l aunch a meani ngf ul i nvest i gat i on

    of Baxt er ' s al l eged mi sconduct bot h bef or e and af t er t he repor t i ng

    pr act i ces changed i n 2000. See Hei neman- Gut a, 718 F. 3d at 36- 37

    ( expl ai ni ng t hat " t o pr ovi de suf f i ci ent not i ce t o t he gover nment of

    t he al l eged f r aud and bar a l at er - f i l ed compl ai nt under

    3730( b) ( 5) [ , ] ear l i er - f i l ed compl ai nt s must pr ovi de onl y t he

    essent i al f act s t o gi ve t he gover nment suf f i ci ent not i ce t o

    i ni t i at e an i nvest i gat i on i nt o al l egedl y f r audul ent pr acti ces") .

    III.

    I n aski ng us t o r ever se t he Di st r i ct Cour t , Sun and

    Hami l t on make an i nt ui t i vel y appeal i ng cont ent i on. The Supr eme

    Cour t has expl ai ned t hat " [ s] eeki ng t he gol den mean between

    adequat e i ncent i ves f or whi st l e- bl owi ng i nsi der s wi t h genui nel y

    val uabl e i nf or mat i on and di scour agement of oppor t uni st i c pl ai nt i f f s

    who have no si gni f i cant i nf or mat i on t o cont r i but e of t hei r own" i s

    one cent r al pur pose of t he Fal se Cl ai ms Act ' s qui t am pr ovi si ons.

    Gr aham Cnt y. Soi l & Wat er Conservat i on Di st . v. Uni t ed St at es ex

    -27-

  • 7/26/2019 US, ex rel. Sun v. Baxter Healthcare Corporation, 1st Cir. (2014)

    28/29

    r el . Wi l son, 559 U. S. 280, 294 ( 2010) ( quot i ng Uni t ed St ates ex

    r el . Spr i ngf i el d Ter mi nal Ry. Co. v. Qui nn, 14 F. 3d 645, 649 ( D. C.

    Ci r . 1994) ) . And her e, Sun and Hami l t on - - a f or mer hi gh- r anki ng

    empl oyee of Baxt er and an empl oyee of one of Baxt er ' s l ongt i me

    cust omer s, r espect i vel y - - ar e "whi st l e- bl owi ng i nsi der s, " not

    "oppor t uni st i c pl ai nt i f f s who have no si gni f i cant i nf or mat i on t o

    cont r i but e of t hei r own. " Fur t her more, Sun and Hami l t on warn t hat ,

    i f we appl y t he f i rst - t o- f i l e rul e t o bar t hei r sui t , i ns i ders l i ke

    t hem wi l l be di scour aged f r om comi ng f or war d wi t h val uabl e

    i nf or mat i on about pot ent i al f r aud f or f ear a l ess knowl edgeabl e

    r el at or al r eady beat t hem t o t he door .

    But consi der ed mor e f ul l y, Sun and Hami l t on' s cont ent i on

    i s not so power f ul . Al t hough achi evi ng t hat " gol den mean" i s

    cer t ai nl y one key pur pose of t he Fal se Cl ai ms Act ' s f i r st - t o- f i l e

    r ul e, we have pr evi ousl y expl ai ned t hat anot her i s " t o pr ovi de

    i ncent i ves t o r el at or s t o pr ompt l y al er t [ ] t he gover nment t o t he

    essent i al f act s of a f r audul ent scheme. " Wi l son, 750 F. 3d at 117

    ( al t er at i on i n or i gi nal ) ( quot i ng Duxbur y, 579 F. 3d at 24) . Sun

    and Hami l t on' s pr ef er r ed appr oach mi ght wel l f r ust r at e t hat goal .

    I f adopt ed, i nsi der s who knew more about a f r aud mi ght have l ess

    r eason t o come f or war d qui ckl y. They woul d f ace l ess r i sk t hat

    di l i gent r el at or s who di d not know as much, but st i l l knew enough

    t o per mi t t he gover nment t o l aunch a meani ngf ul i nvest i gat i on i nt o

    t hat same f r aud, woul d beat t hemt o cour t . I t i s not cl ear why t he

    -28-

  • 7/26/2019 US, ex rel. Sun v. Baxter Healthcare Corporation, 1st Cir. (2014)

    29/29

    pr ovi si on of t he Act t hat est abl i shes t he f i r st- t o- f i l e r ul e shoul d

    be r ead t o di scour age i nsi der s f r om act i ng pr ompt l y on t hei r

    knowl edge.

    But however one mi ght choose t o make the t r adeof f bet ween

    speed and qual i t y i n t he abst r act , our pr ecedent s make cl ear how we

    must make i t her e. Sect i on 3730( b) ( 5) of t he Fal se Cl ai ms Act

    pr event s Sun and Hami l t on' s sui t f r om goi ng f or war d. Thei r

    compl ai nt mer el y pr ovi des " addi t i onal f act s and det ai l s about t he

    same scheme" pl ed i n Ven- A- Car e' s ear l i er - f i l ed compl ai nt ,

    Hei neman- Gut a, 718 F. 3d at 36, whi ch al r eady pr ovi ded t he

    "essent i al f act s" about t hat same scheme. The deci si on di smi ssi ng

    Sun and Hami l t on' s sui t i s t her ef ore AFFI RMED.

    -29-